表紙
市場調査レポート

米国のビタミンD検査市場 (2015〜2019年)

Vitamin D Testing Market in the US 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 347970
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
米国のビタミンD検査市場 (2015〜2019年) Vitamin D Testing Market in the US 2015-2019
出版日: 2015年12月23日 ページ情報: 英文 72 Pages
概要

米国国内のビタミンD検査市場は、今後は安定的な成長を遂げていくと見られています。同市場の2019年までの年平均成長率 (CAGR) は約4%と推計されています。様々な急性・慢性疾患の予防が、主な市場成長要因となっています。ビタミンDの欠乏症は、くる病や骨粗鬆症といった慢性疾患や、幼児期での心血管疾患・がん・ぜんそく発症、認知障害、自己免疫などを引き起こす可能性があります。逆に、ビタミンDの水準を頻繁に検査することで、こうした疾患を予防し、更には全体的な医療費負担を抑えることが可能となります。主な検査項目には、25-ヒドロキシビタミンD検査と1, 25-ジヒドロキシビタミンD検査の2種類がありますが、全社が全体の約76%を占めています。

当レポートでは、米国におけるビタミンD検査の市場について分析し、検査手法の概要や市場の基本構造、市場規模の動向 (今後5年間の予測値)、用途別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブ・サマリー

  • 分析結果の概略

第2章 分析範囲

  • 分析概要
  • 大手ベンダーの主要製品

第3章 市場分析の手法

  • 分析手法
  • 経済指標

第4章 イントロダクション

  • 市場動向の概略

第5章 米国のビタミンDけんさ市場の現状

  • ビタミンD検査の手法
  • 米国でのビタミンD検査の標準化計画

第6章 米国のビタミンD検査の市場規模の見通し (数量ベース、今後5年間分)

  • 市場規模とその予測

第7章 市場環境

  • 市場概要
  • 市場規模とその予測
  • ファイブフォース分析

第8章 用途別の市場区分

  • 25-ヒドロキシビタミンD検査
  • 1, 25-ジヒドロキシビタミンD検査

第9章 市場促進要因

第10章 促進要因の影響力

第11章 市場の課題

第12章 促進要因・課題の影響力

第13章 市場の動向

第14章 ベンダー環境

  • 競争シナリオ
  • 主要ベンダー分析
  • その他の有力ベンダー

第15章 主要ベンダーの分析

  • Abbott Diagnostics
  • bioMerieux
  • DiaSorin
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

第16章 付録

  • 略語集

第17章 Technavioについて

図表一覧

目次
Product Code: IRTNTR7745

Market outlook of the vitamin D testing market in the US

Technavio's market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.

The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.

Application-based segmentation and analysis of - 25-Hydroxy vitamin D tests & 1,25-Dihydroxy vitamin D test

In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

  • 25-Hydroxy vitamin D tests
  • 1,25-Dihydroxy vitamin D test

Competitive landscape and key vendors - Roche Diagnostics, Abbott Diagnostics

This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price, quality, and breadth of product line, technology, and distribution capabilities to gain maximum prominence in the market.

Key vendors in this market are -

  • Roche Diagnostics
  • Abbott Diagnostics
  • Siemens Healthcare Diagnostics
  • Biomeriux
  • Diasorin
  • Quest Diagnostics

Other prominent vendors analyzed in this market research are Diazyme laboratories, Biokit, ESA Biosciences, Quest Diagnostics Inc., The Vitamin D Company, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Piramal Healthcare, Beckman Coulter, and Becton Dickinson.

Growth drivers, challenges, and upcoming drivers - Vitamin D

Upcoming trends such as the augmented adoption of home vitamin D testing kits are rapidly gaining popularity as they are highly cost efficient. Since this market is facing declining reimbursement, patients have to pay out of their pockets to perform these tests. Therefore, in recent times, it has been observed that many patients prefer carrying out such tests at the convenience of their homes as it reduces the overall expenditure.

This report provides a number of factors contributing to the adoption, limitations, and opportunities of the vitamin D testing market in the US. It also offers an analysis of each factor and an estimation of the extent to which the factors are likely to impact the overall market growth.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the vitamin D testing market in the US?
  • What are the key market trends impacting the growth of the vitamin D testing market in the US?
  • What are the challenges to market growth?
  • Who are the key vendors in the vitamin D testing market in the US?
  • What are the market opportunities and threats faced by the vendors in the vitamin D testing market in the US?
  • Trending factors influencing the market shares of the US?
  • What are the key outcomes of the five forces analysis of the vitamin D testing market in the US?

Technavio also offers customization on reports based on specific client requirement.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Vitamin D status in US

  • Methods for vitamin D testing
  • Standardization program for vitamin D test in US

PART 06: Vitamin D testing market by volume in US 2015-2019

  • Market size and forecast

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by application

  • 25-hydroxy vitamin D test
  • 1, 25-dihydroxy vitamin D test

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

  • Competitive scenario
  • Key prominent vendors
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • bioMerieux
  • DiaSorin
  • Quest Diagnostics
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Vitamin D sources
  • Exhibit 03: FDA approved products for vitamin D testing in US
  • Exhibit 04: Market opportunity for vitamin D testing in chronic kidney diseases
  • Exhibit 05: Phases of standardization program
  • Exhibit 06: Total volume of vitamin D tests performed in US 2015-2019 (millions)
  • Exhibit 07: Segmentation of vitamin D testing market in US
  • Exhibit 08: Vitamin D testing market in US 2015-2019 by sales revenue ($ millions)
  • Exhibit 09: Five forces analysis
  • Exhibit 10: Vitamin D testing market in US based on application
  • Exhibit 11: Vitamin D testing market by application in 2014
  • Exhibit 12: Impact of drivers
  • Exhibit 13: Impact of drivers and challenges
  • Exhibit 14: Abbott Diagnostics: Key takeaways
  • Exhibit 15: bioMerieux: Key takeaways
  • Exhibit 16: DiaSorin: Key takeaways
  • Exhibit 17: Quest Diagnostics: Key takeaways
  • Exhibit 18: Roche Diagnostics: Key takeaways
  • Exhibit 19: Siemens Healthcare Diagnostics: Key takeaways
  • Exhibit 20: Abbott Diagnostics: Key business offerings
  • Exhibit 21: bioMerieux: Applications by technology
  • Exhibit 22: DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 23: DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 24: Quest Diagnostics: Business segmentation
  • Exhibit 25: Quest Diagnostics: Business segmentation by revenue 2014
  • Exhibit 26: Quest Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 27: Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 28: Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 29: Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 30: Siemens Healthcare Diagnostics: Business segmentation
  • Exhibit 31: Siemens Healthcare Diagnostics: Geographical segmentation by revenue 2014
Back to Top